These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11121610)

  • 21. Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.
    Hermann C; Graf K; Groh A; Straube E; Hartung T
    J Clin Microbiol; 2002 May; 40(5):1603-9. PubMed ID: 11980928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae.
    Persson K; Boman J
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):739-44. PubMed ID: 10973447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia.
    Miyashita N; Akaike H; Teranishi H; Kawai Y; Ouchi K; Kato T; Hayashi T; Okimoto N
    J Infect Chemother; 2013 Apr; 19(2):249-55. PubMed ID: 23096022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved sensitivity and specificity of enzyme immunoassays with P1-adhesin enriched antigen to detect acute Mycoplasma pneumoniae infection.
    Tuuminen T; Suni J; Kleemola M; Jacobs E
    J Microbiol Methods; 2001 Feb; 44(1):27-37. PubMed ID: 11166097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia.
    Wellinghausen N; Straube E; Freidank H; von Baum H; Marre R; Essig A
    Int J Med Microbiol; 2006 Nov; 296(7):485-91. PubMed ID: 16890487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG subclass-specific antibodies in Chlamydia pneumoniae infections.
    Anttila T; Leinonen M; Surcel HM; Von Hertzen L; Bloigu A; Seppälä I; Saikku P
    Scand J Infect Dis; 1998; 30(4):381-6. PubMed ID: 9817519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.
    Verkooyen RP; Van Lent NA; Mousavi Joulandan SA; Snijder RJ; van den Bosch JM; Van Helden HP; Verbrugh HA
    J Med Microbiol; 1997 Nov; 46(11):959-64. PubMed ID: 9368538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.
    Halvorsen DS; Børvik T; Njølstad I; Gutteberg TJ; Vorland LH; Hansen JB
    J Intern Med; 2002 Feb; 251(2):142-7. PubMed ID: 11905590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of serologic markers against bacterial atypical pneumonia agents in pneumonia patients].
    Pinar A; Ercis S; Ulukavak T; Dursun B; Hasçelik G
    Mikrobiyol Bul; 2004; 38(1-2):27-32. PubMed ID: 15293899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae.
    Messmer TO; Martinez J; Hassouna F; Zell ER; Harris W; Dowell S; Carlone GM
    Clin Diagn Lab Immunol; 2001 May; 8(3):588-92. PubMed ID: 11329463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological study on Chlamydophila pneumoniae in patients with community-acquired pneumonia.
    Ciarrocchi G; De Benedetto F; Fogliani V; Magliano E; Del Prete R; Miragliotta G
    New Microbiol; 2004 Oct; 27(4):335-43. PubMed ID: 15646047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.
    Hoymans VY; Bosmans JM; Van Renterghem L; Mak R; Ursi D; Wuyts F; Vrints CJ; Ieven M
    J Clin Microbiol; 2003 Sep; 41(9):4049-53. PubMed ID: 12958224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Chlamydia and Chlamydophila spp. IgG and IgM antibodies by microimmunofluorescence with antigen detection methods.
    She RC; Welch R; Wilson AR; Davis D; Litwin CM
    J Clin Lab Anal; 2011; 25(4):305-8. PubMed ID: 21786334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Chlamydophila pneumoniae IgG in paired serum samples: comparison of serological techniques in pneumonia cases.
    De Ory F; Guisasola ME; Eiros JM
    APMIS; 2006 Apr; 114(4):279-84. PubMed ID: 16689827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of enzyme-linked immunosorbent assay for Chlamydophila pneumoniae-specific immunoglobulin M in acute respiratory tract infection.
    Miyashita N; Ouchi K; Kawasaki K; Komura H; Kawai Y; Obase Y; Kobashi Y; Oka M
    Respirology; 2008 Mar; 13(2):299-302. PubMed ID: 18339033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad.
    Nagalingam NA; Adesiyun AA; Swanston WH; Bartholomew M
    New Microbiol; 2004 Oct; 27(4):345-51. PubMed ID: 15646048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci.
    Freidank HM; Vögele H; Eckert K
    Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):685-8. PubMed ID: 9352264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.
    Wong YK; Sueur JM; Fall CH; Orfila J; Ward ME
    J Clin Pathol; 1999 Feb; 52(2):99-102. PubMed ID: 10396235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.
    Paldanius M; Bloigu A; Alho M; Leinonen M; Saikku P
    Clin Diagn Lab Immunol; 2005 May; 12(5):654-9. PubMed ID: 15879028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.